January 28, 2026
Support from The Michael J. Fox Foundation for Parkinson’s Research to advance critical research into Parkinson’s disease biology Nautilus’ development of a single-molecule assay for measuring alpha-synuclein proteoforms is its latest application of Iterative Mapping method to uncover new biological insights Weill Cornell Medicine-Qatar’s deep chemical biology and neurology expertise and field-leading protein standards and [...]
January 28, 2026
Detects low-abundance proteins in blood at femtogram concentrations for earlier disease insights Supports research in Alzheimer's, ALS, MS, Parkinson's Disease, and Traumatic Brain Injury with validated biomarkers Automated immunoassay workflow reduces variability; total runtime is under three hours MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced [...]
SeekGene Launches High-Throughput Single-Cell DNA Methylation + RNA Multi-Omics Solution
January 28, 2026
New platform integrates epigenetic and transcriptomic analysis in a unified workflow, addressing key challenges in single-cell multi-omics research. LONDON, UK – SeekGene, a biotechnology company specializing in single-cell technology platforms, announced the launch of its novel high-throughput single-cell DNA methylation and RNA multi-omics solution at the Festival of Genomics & BioData 2026. The solution aims to [...]
iOrganBio Appoints Karol Jarzabek as Chief Operating Officer
January 27, 2026
Adds Private Equity and Operational Experience to Help Scale iOrganBio’s Operations CHAPEL HILL, N.C. -- iOrganBio, an innovator in intelligent cell manufacturing redefining how human cells are engineered and reliably produced at scale for research and therapy, including as New Approach Methodologies (NAMs) in alignment with FDA direction, today announced the appointment of Karol Jarzabek [...]
Waters Shareholders Approve Combination with BD’s Biosciences & Diagnostic Solutions Business
January 27, 2026
Waters Corporation's Q4 2025 Financial Results Conference Call will now be held on Monday, February 9th, 2026 at 8:30am ET in conjunction with the expected close of the transaction MILFORD, Mass. -- Waters Corporation (NYSE: WAT) (the "Company" or "Waters") today announced that, at the Company's Special Meeting of Shareholders (the "Special Meeting") held today, Waters [...]
January 27, 2026
Expansion of iXCells’ iPSCore platform with integration of 3D human organoid expertise will enable evaluation of drug toxicity and tissue-specific responses Responds to growing demand for scalable, patient-relevant human models to support translational decision-making in drug development San Diego, CA: iXCells Biotechnologies (“iXCells”), a leading provider of human cell-based solutions and custom iPSC services, and Rosebud [...]
January 27, 2026
Solna, Sweden – Epigenica AB announces the launch of its EpiFinder™ Analysis Service, a fully managed, high-throughput platform designed to make advanced epigenomic research faster, more accessible and highly reproducible. The EpiFinder™ Analysis Service provides comprehensive, end-to-end support by managing every step of the workflow, from study design and sample logistics to sequencing, data processing, and [...]
Pixelgen Technologies Appoints Chief Commercial Officer to Lead Global Expansion
January 27, 2026
Life sciences executive brings 20-plus years’ experience in biopharma and diagnostics, with precision oncology expertise STOCKHOLM — Pixelgen Technologies today announced the appointment of life sciences executive Nis Glavind Kruse as the company’s Chief Commercial Officer. Kruse will lead Pixelgen’s global commercial organization as the company accelerates adoption of its Pixelgen Proxiome Kit and new technologies enabling advanced protein interactomics research [...]
Evosep Launches IQ/OQ Protocols for the Evosep Eno System at WCBP 2026
January 27, 2026
Washington, D.C., – WCBP – Evosep is proud to announce a major advancement in quality assurance for pharmaceutical and regulated laboratories with the introduction of Installation Qualification (IQ) and Operational Qualification (OQ) protocols for its Evosep Eno system. This milestone will be showcased at the WCBP Symposium in Washington, reinforcing Evosep’s commitment to enable seamless integration [...]
January 27, 2026
Foster City, Calif. — Signios Bio today announced the launch of a new grant program supporting innovative spatial transcriptomics research using the 10x Genomics Xenium 5K Spatial Transcriptomics platform. The program is designed to enable U.S.-based researchers to generate high-plex, single-cell-resolution spatial gene expression data in human and mouse tissues. The Signios Bio Xenium 5K Spatial [...]

